SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending following its recent earnings report, which, despite beating analyst expectations on key metrics, saw the stock experience a notable drop. Bulls view this as an oversold opportunity to buy, highlighting robust subscriber growth and expanding ad revenue, while bears point to cautious forward guidance and the pause in share buybacks as concerns, especially with the ongoing Warner Bros. acquisition discussions.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as investors flock to gold amidst escalating geopolitical tensions, driven by recent tariff threats against European nations linked to discussions around Greenland. This has ignited fears of a global trade conflict and broader market instability, leading the community to embrace gold as a crucial safe-haven and non-political reserve asset.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas ($BOIL) is surging dramatically due to extreme cold weather forecasts and polar vortex threats across the US, signaling expectations of substantial natural gas demand and potential production impacts. The community is abuzz with discussions of massive gains and short squeezes, grappling with the asset's inherent volatility as many celebrate long positions while others caution about a potential reversal. This intense debate reflects the highly weather-sensitive nature of natural gas and its leveraged ETFs.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is experiencing significant volatility, declining sharply as natural gas prices surge amidst forecasts for an intense cold snap and potential polar vortex activity, which is driving up heating demand. This dramatic movement has fueled extensive community debate, with many viewing KOLD's steep drop as a potential "buy the dip" opportunity while others caution about the inherent risks and rapid reversals characteristic of leveraged natural gas products.

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals is actively trending following strong financial performance for its key product and a strategic acquisition that diversifies its oncology pipeline. The community is heavily debating a potential buyout, fueled by unusual options activity and the company's perceived undervaluation amid a consolidating biotech market.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

The United States Natural Gas Fund ($UNG) is experiencing significant upward momentum driven by widespread forecasts for brutal arctic cold and winter storms across key demand regions, sparking intense bullish sentiment. This sharp rebound is fueling active community debate, with many traders anticipating a short squeeze while others remain wary of natural gas's historical volatility and high production levels. Beyond immediate weather, the community is also discussing increasing long-term demand from LNG exports and emerging needs from AI data centers.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending amidst a sharply divided community, driven by the impending TikTok U.S. operations deal, expected to finalize around January 22nd, which bulls anticipate will fuel a significant rebound. However, this optimism is significantly challenged by a recent bondholder lawsuit alleging undisclosed debt for its ambitious AI infrastructure buildout. Bears are amplifying concerns over the company's escalating debt and potential financial risks, creating a volatile debate between long-term growth prospects in AI and immediate solvency fears.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X Shares

Direxion Daily TSLA Bull 2X Shares

TSLL is seeing significant trading volume as market participants grapple with the volatile movements of its underlying asset, TSLA. Bulls are aggressively buying dips, anticipating a strong rebound from key support levels and potential positive catalysts for TSLA, while bears warn of the inherent decay in leveraged ETFs and raise concerns about valuation. Adding to the immediate discussion, TSLL's recent unexpected dividend distributions have introduced complications for options traders.

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies (ROLR) is trending following news of a direct offering and strategic agreements to launch U.S. prediction markets. The community is actively debating the stock's valuation, with many investors viewing current trading levels below the offering price as a compelling buying opportunity. This sentiment is amplified by high short interest and the company's push into the rapidly expanding prediction markets sector.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending with significant community enthusiasm surrounding its strategic pivot towards AI cloud infrastructure, underscored by its substantial Microsoft deal and whispers of further partnerships with major AI sector players. Its strong performance, often decoupling from Bitcoin trends, is attributed to its valuable power assets and data center capacity, a critical advantage in the booming AI compute market. Positive analyst upgrades and favorable trade developments, like the U.S.-Taiwan deal impacting AI chip tariffs, are further fueling bullish sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Galectin Therapeutics Inc. (NASDAQ:GALT) Short Interest Update

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) was the target of a significant drop in short interest during the month of December. As of December 31st, there was short interest totaling...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Galectin Therapeutics (NASDAQ:GALT) CEO Joel Lewis Sells 18,571 Shares

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CEO Joel Lewis sold 18,571 shares of the business's stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an...

Insider Selling: Galectin Therapeutics (NASDAQ:GALT) CFO Sells 20,354 Shares of Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CFO Jack Callicutt sold 20,354 shares of the company's stock in a transaction on Tuesday, January 6th. The stock was sold at an average...

Khurram Jamil Sells 21,446 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) insider Khurram Jamil sold 21,446 shares of the firm's stock in a transaction that occurred on Tuesday, January 6th. The shares were sold at...

Khurram Jamil Sells 25,499 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) insider Khurram Jamil sold 25,499 shares of the business's stock in a transaction on Monday, January 5th. The shares were sold at an average...

Insider Selling: Galectin Therapeutics (NASDAQ:GALT) CFO Sells 25,732 Shares of Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CFO Jack Callicutt sold 25,732 shares of the stock in a transaction dated Monday, January 5th. The stock was sold at an average price of...

Joel Lewis Sells 27,731 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CEO Joel Lewis sold 27,731 shares of Galectin Therapeutics stock in a transaction dated Monday, January 5th. The shares were sold at an...

Galectin Therapeutics (NASDAQ:GALT) CEO Joel Lewis Sells 37,698 Shares

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CEO Joel Lewis sold 37,698 shares of Galectin Therapeutics stock in a transaction on Tuesday, January 6th. The stock was sold at an average...

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Current Price	$2.99
Prev Close	$3.04
Open	$3.02
Dividend Yield	0.00%
50-Day Moving Average	$4.92
Beta	0.50
Avg. Volume	765,439.09
PE Ratio	-5.06

52-Week High	$7.13
52-Week Low	$1.12
Market Capitalization	$196.02M
EPS (Annual)	-$0.7575
Price to Book	-1.53
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

GALT
Galectin Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GALT News

GALTGalectin Therapeutics Inc